In 2017 the Camden Coalition of Healthcare Providers began a pilot in partnership with local addiction treatment providers and UnitedHealthCare to see if removing prior authorization requirements for buprenorphine would reduce barriers to treatment and improve patient and system outcomes.
A 2011 report about how Kentucky’s drug courts access and use data from the state’s prescription drug monitoring program (PDMP) from the PDMP Center of Excellence at Brandeis University.
Arizona’s Department of Health Services adopted an enhanced opioid data surveillance program that requires first responders and health care providers to report suspected opioid overdoses, suspected opioid overdose deaths, naloxone distribution, and naloxone administration through an electronic reporting system. Providers are also required to report suspected cases of neonatal opioid withdrawal syndrome (neonatal abstinence syndrome). In addition, the state provides blood testing from suspected opioid overdoses by the public health laboratory and has a real time opioid data online dashboard. Links the project website, copies of the executive order and regulations, frequently asked questions, and implementation guides are available below.
The Arizona Department of Health Services prepared this 2017 review of opioid related policies in all 50 states to assist decision-makers in evaluating potential policy actions. The review includes appendices which address topics such as prescribing regulations and guidelines, data collection, state substance abuse task forces, and state emergency response declarations. The reports are available for download below.
The Kaiser Family Foundation’s Covid-19 resources page includes data and information on federal and state responses to the public health emergency. The site has data and charts summarizing the following:
The Covid-19 resources page of the Cochrane Collaboration. Cochrane provides high-quality, relevant, and up-to-date synthesized research evidence to inform health decisions.
The Covid-19 resources page of the Institute for Health Metrics and Evaluation (IMHE) of the University of Washington includes an IHME developed model to predict demand for hospital services during this public health emergency in each state.
This 4 page research brief from Altarum authored by C.N. Rhyan analyzes 2016 data to estimate the economic impact of eliminating the opioid epidemic. The analysis looks at 2 categories of impact.
The Minnesota legislature asked the state Department of Management and Budget (MMB) to do impact evaluations of certain opioid-related state grants. Staff at MMB created this two page guide to briefly explain what impact evaluations are and what is required to conduct an effective impact evaluation.
The Healthcare Cost and Utilization Project (HCUP) is a collaborative federal-state-industry data project that provides encounter-level health care data. This link is to the dashboard for data on neonatal abstinence syndrome or neonatal opioid withdrawal syndrome in newborn hospitalizations.